Haemorrhagic Transformation after Ischaemic Stroke in Patients Taking Non-vitamin K Antagonist Oral Anticoagulants
Jan C. Purrucker, Kirsten Haas, Marcel Wolf, Timolaos Rizos, Shujah Khan, Peter Kraft, Sven Poli, Rainer Dziewas, Johannes Meyne, Frederick Palm, Sebastian Jander, Markus Möhlenbruch, Peter U. Heuschmann, Roland Veltkamp,
J Stroke. 2017;19(1):67-76.   Published online 2017 Jan 31     DOI: https://doi.org/10.5853/jos.2016.00542
Citations to this article as recorded by Crossref logo
Rationale and design of the Registry of Acute Stroke Under Novel Oral Anticoagulants-prime (RASUNOA-prime)
Kirsten Haas, Jan C Purrucker, Timolaos Rizos, Peter U Heuschmann, Roland Veltkamp
European Stroke Journal.2019; 4(2): 181.     CrossRef
Clinical presentation, diagnostic findings and management of cerebral ischemic events in patients on treatment with non-vitamin K antagonist oral anticoagulants – A systematic review
Thomas Raphael Meinel, Sebastién Frey, Marcel Arnold, Sarah Kendroud, Urs Fischer, Johannes Kaesmacher, Mirjam Rachel Heldner, Simon Jung, Marcel M. Daadi
PLOS ONE.2019; 14(3): e0213379.     CrossRef
Patients on NOACs in the Emergency Room
Stefan T. Gerner, Hagen B. Huttner
Current Neurology and Neuroscience Reports.2019;[Epub]     CrossRef